Loading viewer...
conference
Format: PDF conference
Presentation delivered at the 41st Annual J.P. Morgan Healthcare Conference in January 2023. The company is advancing development programs across multiple therapeutic areas including Alzheimer's, Parkinson's, Migraine, and Hypercholesterolemia, with discussions of discovery, research activities, and anticipated clinical development timelines for product candidates.
investor_presentation
18 Pages
conference
31 Pages
BioPorto
Colgate-Palmolive 2016 Barclays Consumer Staples Conference
conferenceconference
108 Pages
Colgate-Palmolive Company
Northern Minerals 2023 UBS Resources Corporate Day
conferenceconference
26 Pages
Northern Minerals Limited